To clarify the roles of RSK2 in the proliferation of MCL cells, we examined the effects of pharmacologic inhibition of RSK2‐NTKD by BI‐D1870 and of RSK2‐CTKD by FMK in these cells. This evidence concerns the gene RPS6KA3 and mantle cell lymphoma.